Guaifenesin

MIAMI, March 5, 2024 /PRNewswire/ -- Healthy Together, a leading health technology company specializing in Software as a Service (SaaS) solutions for State-level Health & Human Services programs, is excited to announce the successful acquisition of Kinsa Health, a powerful and robust AI platform that provides predictive insights for pharmaceutical companies, retailers, illness product companies, public health agencies, hospital systems, and communities. The acquisition advances Healthy Together's mission to improve collective health and make government and enterprises more efficient. By integrating Kinsa's AI illness forecasting engine into Healthy Together's SaaS platform, Healthy Together is poised to revolutionize population health management, ensuring better outcomes and faster and more effective interventions. Kinsa's innovative approach to early warning and predictive analytics complements Healthy Together's commitment to leverage technology for the greater good. The synergy between the two companies will empower pharmaceutical companies, healthcare providers, Medicaid agencies, insurance companies, and public health departments with AI-driven tools to proactively respond to and address illness. Early detection supports rapid interventions throughout the public and private healthcare ecosystem. "This acquisition represents a significant investment in AI to expand the Kinsa service and predictive model. By combining Kinsa's AI illness forecasting with our robust SaaS solutions, we can create and support a more resilient and responsive public and private health infrastructure. We're excited to have key Kinsa team members join the Healthy Together family, further strengthening our capabilities and efforts to bring the Healthy Together platform to Kinsa's customer base," said Jared Allgood, President of Healthy Together. Kinsa customers like CVS, Clorox, Mucinex, Proctor & Gamble and others have utilized real-time and AI forecasted data to predict up to 8 weeks out where illness is on the rise and where demand for doctor visits, vaccines, and medicines will surge. The AI model empowers organizations to allocate resources effectively, ensuring people have access to the illness products, vaccines, and remedies they need when they are sick. Working with a customer in the Washington D.C. area alone, Kinsa identified $69M of increased illness-based demand 4 weeks before it happened, which prevented stock-outs across the region. "I am grateful that Kinsa has found a home with Healthy Together and that our customers - millions of households across the country that use the Kinsa thermometer and app to help keep their families healthy, and numerous organizations that have used Kinsa Insights to predict where and when infectious illness will affect Americans, including health systems, public health agencies, major OTC medicines makers, and retailers - will be able to benefit from Kinsa's unique technology and products in the future," said Inder Singh, Founder of Kinsa Health. The Kinsa Insights AI platform is powered by over 3 million "smart" thermometers already in use and available for purchase through retailers such as CVS, Walgreens, Amazon, Best Buy, and more. Both the Kinsa QuickScan (non-contact thermometer) and Kinsa QuickCare (stick thermometer) devices link to a mobile app to provide individuals with accurate temperature readings, symptom tracking, and real-time health recommendations. This acquisition reinforces Healthy Together's commitment to driving positive change in public health outcomes. About Healthy Together: Healthy Together is a health technology company that builds SaaS technology for government, education, and enterprise. Their technology is used for disease surveillance, behavioral health management, and benefit enrollment for programs like Medicaid, Supplemental Nutrition Assistance Program, and WIC. Healthy Together's mobile application has reached #1 in the App Store Health & Fitness category and has over 225k reviews on the App Store and Play Store with a 4.9/5 star rating. To learn more about Healthy Together's solutions, visit About Kinsa: Kinsa is a powerful and robust early warning and predictive system that provides real-time insights for entire communities to be equipped to stop the spread of infectious illness. With a focus on leveraging technology for public health, Kinsa's solutions have been at the forefront of early detection and proactive management of infectious diseases. To learn more about Kinsa's solutions, visit SOURCE Healthy Together

Brand's New "Power of 12" Campaign Shines a Light on How Mucinex 12-Hour Helps Consumers Make Up for Lost Time PARSIPPANY, N.J., Jan. 12, 2024 /PRNewswire/ -- Over the last year, how many days did you feel sick and not at your best? In a recent survey of 2,000 adults, Americans responded that they're on their "A" game only about 15 days per month. What's more, 46% of Americans admit that they actively worry about missing out on important events and experiences with their loved ones. That's why Mucinex 12-Hour, the #1 doctor recommended expectorant, today announced the launch of its new "Power of 12" campaign, an initiative that kicks off on 1/12 to spotlight its efficacy: one little pill that delivers 12 full hours of symptom relief, so they can spend less time suffering, and more time doing the things you love. Continue Reading Mucinex 12-Hour Americans certainly wish they had more hours in the day, according to key results from the survey, commissioned by Mucinex and conducted by market research company OnePoll. The top three reasons Americans tend to feel unwell: lack of sleep (43%), excessive stress (43%) and being sick (22%). More specifically, the survey found: Americans lost about 26 hours of quality time with their loved ones in 2023, missing eight important social events and cancelling nine dates because they didn't feel their best. Additionally, 62% claim they missed approximately four days of work in 2023 and spent another four full days in bed, because they were sick with cold or flu. The average respondent lost more than $350 from missing work, visiting the doctor, or purchasing medications. Because Mucinex 12-Hour lasts three times longer than four-hour medications, controlling cough and cold symptoms for up to 12 full hours, consumers needn't lose as much time and money just because they happen to be sick. Instead, they can get back more quickly to doing all the things they love: spending time with family (42%), reading (26%) and hanging out with friends and pets (both at 26%). In fact, 60% of respondents think there aren't enough hours in the day even when they're feeling healthy, which may explain why half of respondents try to carry on as usual when they're sick. "These days, our schedules are more packed than ever and we're constantly on the go. That's why a long-lasting symptom reliever like Mucinex 12-Hour is a must-have for any medicine cabinet, especially in the middle of cold and flu season, so you can get back to pursuing your passions, achieving your goals, and spending more quality time with friends and family," said Albert So, Marketing Director, Upper Respiratory Brands at Reckitt. "Because it provides immediate and extended relief for up to 12 hours, one dose of this powerful formula can help give you quality time back." Generational differences don't negate that all respondents feel important things are missed while under the weather. Millennials prefer spending their healthy hours on creative projects (24%) while Baby Boomers enjoy going out to eat (32%). Gen Z values spending time with family and friends (30%) as do Boomers (33%), while 15% of Millennials would rather spend that extra time looking for love. If an extra 12 hours were added to the day, most Americans would rather enjoy a little R&R than focus on productivity (47% vs. 39%). Gen Z is the outlier here; they'd much rather be productive than relax (48% vs. 38%). You can stop by Walmart, Target, your local pharmacy, or nearest food retailer to buy Mucinex. Visit for more information. Contact: Amanda Pisano at [email protected] Survey Methodology This random double-opt-in survey of 2,000 Americans split evenly by generation (500 Gen Z, 500 millennials, 500 Gen X and 500 baby boomers) was commissioned by Mucinex between Dec. 1 and Dec. 5, 2023. It was conducted by market research company OnePoll, whose team members are members of the Market Research Society and have corporate membership to the American Association for Public Opinion Research (AAPOR) and the European Society for Opinion and Marketing Research (ESOMAR). About Reckitt Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege. Reckitt is the company behind some of the world's most recognizable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more. Every day, more than 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always. We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at . * Reckitt is the trading name of the Reckitt Benckiser group of companies. SOURCE Mucinex